SGLT2i Safety in Acute Heart Failure Confirmed by New Data SGLT2i Safety in Acute Heart Failure Confirmed by New Data

Results of the DICTATE-AHF randomized trial that tested starting dapagliflozin for patients hospitalized with acute heart failure confirmed the safety and benefit of this guideline-directed strategy.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Cardiology News Source Type: news